Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Mar. 31, 2021
Current assets    
Cash and cash equivalents $ 1,991,377 $ 608,348
Accounts receivable 274,844 451,905
Prepaid expenses and other current assets 1,127,362 1,680,557
Inventories 1,191,020 692,163
Total Current assets 4,584,603 3,432,973
Equipment 91,234 93,577
Intangible assets, net 0 976,551
Goodwill 0 4,282,984
Total assets 4,675,837 8,786,085
Current liabilities    
Accounts payable 305,095 454,809
Accrued liabilities 873,030 760,026
Convertible notes 0 2,152,334
PPP loan 0 459,912
Deferred revenue, current portion 313,854 268,083
Total current liabilities 1,491,979 4,095,164
Deferred revenue, net of current portion 256,646 303,917
Demand loans, net of current portion 0 1,105,974
Total liabilities 1,748,625 5,505,055
Commitments and contingencies (Note 13)
Stockholders' Equity    
Preferred stock, $0.001 par value; Authorized 5,000,000, Issued none Special voting preferred stock, $0.001 par value; Authorize; Issued - 1 0 0
Common stock, par value $0.001; Authorized - 13,000,000; Issued 6,767,114 and 112,440 Exchangeable Shares (March 31, 2021 - 5,589,375 and 112,440 Exchangeable Shares) 6,879 5,702
Additional paid-in capital 98,294,558 88,227,506
Accumulated deficit (95,402,321) (84,994,327)
Accumulated other comprehensive income 28,096 42,149
Total stockholders' equity 2,927,212 3,281,030
Total liabilities and stockholders' equity $ 4,675,837 $ 8,786,085